Tomi K Sawyer Selected Research

AP23236

9/2003

Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomi K Sawyer Research Topics

Disease

17	Neoplasms (Cancer) 07/2022 - 09/2003
6	Osteoporosis 01/2020 - 09/2003
6	Bone Diseases (Bone Disease) 01/2020 - 01/2002
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2010 - 10/2004
4	Bone Resorption 02/2008 - 09/2003
3	Neoplasm Metastasis (Metastasis) 12/2005 - 09/2003
2	Carcinoma (Carcinomatosis) 09/2006 - 02/2005
2	Adenocarcinoma 01/2006 - 12/2005
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Multiple Myeloma 01/2020
1	Hypercalcemia (Milk Alkali Syndrome) 02/2008
1	Ovarian Neoplasms (Ovarian Cancer) 09/2006
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 07/2005
1	Systemic Mastocytosis 07/2005
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2005
1	Colonic Neoplasms (Colon Cancer) 02/2005

Drug/Important Bio-Agent (IBA)

8	src-Family KinasesIBA 10/2006 - 01/2002
6	Pharmaceutical PreparationsIBA 01/2020 - 09/2003
6	Phosphotransferases (Kinase)IBA 06/2010 - 01/2002
5	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2004
4	Diphosphonates (Bisphosphonates)IBA 01/2020 - 09/2003
3	Focal Adhesion Protein-Tyrosine KinasesIBA 07/2022 - 01/2004
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2010 - 09/2006
3	EnzymesIBA 10/2006 - 09/2003
2	Protein Kinases (Protein Kinase)IBA 06/2013 - 01/2002
2	Imatinib Mesylate (Gleevec)FDA Link 11/2009 - 06/2006
2	AP23846IBA 09/2006 - 12/2005
2	Interleukin-8 (Interleukin 8)IBA 01/2006 - 12/2005
2	Adenosine Triphosphate (ATP)IBA 12/2005 - 09/2003
2	Protein Kinase InhibitorsIBA 09/2004 - 01/2004
1	EpitopesIBA 12/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	ATSP-7041IBA 09/2013
1	Peptides (Polypeptides)IBA 09/2013
1	Investigational DrugsIBA 06/2013
1	HydrocarbonsIBA 04/2010
1	ponatinibIBA 11/2009
1	nilotinib FDA Link 11/2009
1	Dasatinib (BMS 354825)FDA Link 11/2009
1	AP 24163IBA 08/2009
1	AP 23451IBA 02/2008
1	Docetaxel (Taxotere)FDA Link 09/2006
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2006
1	NF-kappa B (NF-kB)IBA 01/2006
1	Biological ProductsIBA 12/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2005
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2005
1	AP23464IBA 07/2005
1	AP23848IBA 07/2005
1	bcr-abl Fusion ProteinsIBA 10/2004
1	GTP Phosphohydrolases (GTPases)IBA 01/2004
1	IntegrinsIBA 01/2004
1	ErbB Receptors (EGF Receptor)IBA 01/2004
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2004
1	Metalloproteases (Metalloproteinases)IBA 01/2004
1	raf KinasesIBA 01/2004
1	GeranyltranstransferaseIBA 01/2004
1	AP22408IBA 09/2003
1	LigandsIBA 09/2003
1	PurinesIBA 09/2003
1	AP23236IBA 09/2003
1	Zoledronic Acid (Zometa)FDA Link 09/2003
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 09/2003

Therapy/Procedure

8	Therapeutics 12/2021 - 09/2003
1	Oral Administration 08/2009